These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11885450)

  • 1. Evolution of saliva and serum components in patients with oral candidosis topically treated with Ketoconazole and Nystatin.
    Cornejo LS; López de Blanc S; Femopase F; Azcurra A; Calamari S; Battellino LJ; Dorronsoro de Cattoni ST
    Acta Odontol Latinoam; 1998; 11(1):15-25. PubMed ID: 11885450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum and saliva components in candidosis patients.
    Dorronsoro de Cattoni ST; Cornejo LS; López de Blanc S; Calamari S; Femopase F; Azcurra AI; Battellino LJ
    Acta Odontol Latinoam; 1997; 10(2):133-48. PubMed ID: 11885239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal topical therapy in oral chronic candidosis. A comparative study.
    Lopez-De-Blanc SA; Salati-De-Mugnolo N; Femopase FL; Benitez MB; Morelatto RA; Astrada-De-Verde L; Masih D
    Med Oral; 2002; 7(4):260-70. PubMed ID: 12134127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study.
    Geerts GA; Stuhlinger ME; Basson NJ
    J Oral Rehabil; 2008 Sep; 35(9):664-9. PubMed ID: 18793352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral candidiasis in HIV-seropositive patients and AIDS cases. Clinical, mycological and therapeutical aspects].
    Prieto Santa Anna LM; Illnait Zaragozi MT; Ramos Rodallegas EG; Lazcano Herrero B; Márquez Sánchez N; Cantelar de Francisco N; Manzur Katriba J; Martínez Machin G
    Rev Cubana Med Trop; 2006; 58(3):173-80. PubMed ID: 23424783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents.
    Ohnemus U; Willers C; Bubenheim M; Horstkotte MA; Houdek P; Fischer F; Schmage P; Moll I; Brandner JM
    Mycoses; 2008 Jan; 51(1):21-9. PubMed ID: 18076591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antifungal agents for oral candidiasis: results of a national survey.
    Martínez-Beneyto Y; López-Jornet P; Velandrino-Nicolás A; Jornet-García V
    Int J Dent Hyg; 2010 Feb; 8(1):47-52. PubMed ID: 20096082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Photodynamic Therapy versus conventional antifungal therapy for the treatment of denture stomatitis: a randomized clinical trial.
    Mima EG; Vergani CE; Machado AL; Massucato EM; Colombo AL; Bagnato VS; Pavarina AC
    Clin Microbiol Infect; 2012 Oct; 18(10):E380-8. PubMed ID: 22731617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis.
    Koray M; Ak G; Kurklu E; Issever H; Tanyeri H; Kulekci G; Guc U
    Oral Dis; 2005 Sep; 11(5):309-13. PubMed ID: 16120118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
    Romero-Cerecero O; Rojas G; Navarro V; Herrera-Arellano A; Zamilpa-Alvarez A; Tortoriello J
    Planta Med; 2006 Nov; 72(14):1257-61. PubMed ID: 17051456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral candidosis. Clinical, historical, and therapeutic features of 100 cases.
    Fotos PG; Vincent SD; Hellstein JW
    Oral Surg Oral Med Oral Pathol; 1992 Jul; 74(1):41-9. PubMed ID: 1508508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mucoadhesive extended release tablets for treatment of oral candidosis: "in vivo" evaluation of the biopharmaceutical performance.
    Llabot JM; Manzo RH; Allemandi DA
    J Pharm Sci; 2009 May; 98(5):1871-6. PubMed ID: 18803261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, double-blind, placebo-controlled trial evaluating the effect of nystatin on the development of oral irritation in patients receiving high-dose intravenous interleukin-2.
    Ohnmacht GA; Phan GQ; Mavroukakis SA; Steinberg SM; Shea YR; Witebsky FG; McIntyre LS; Goodwin RS; Muehlbauer PM; Morton KE; Rogers-Freezer LJ; Seipp CA; Rosenberg SA; Marincola FM
    J Immunother; 2001; 24(2):188-92. PubMed ID: 11265777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole versus nystatin in the treatment of oral candidosis.
    Blomgren J; Berggren U; Jontell M
    Acta Odontol Scand; 1998 Aug; 56(4):202-5. PubMed ID: 9765010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole versus ketoconazole in the treatment of tinea versicolor.
    Farschian M; Yaghoobi R; Samadi K
    J Dermatolog Treat; 2002 Jun; 13(2):73-6. PubMed ID: 12060505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
    Blignaut E; Botes ME; Nieman HL
    SADJ; 1999 Dec; 54(12):605-8. PubMed ID: 16892568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.